The Florida Heart Research Institute has named Dr. Dominick J. Angiolillo, Associate Director of Cardiovascular Research at the University of Florida/Jacksonville, its fourth “Stop Heart Disease Researcher of the Year” at the annual meeting of the Florida Chapter of the American College of Cardiology (FCACC).
Dr. Dominick J. Angiolillo and Kathleen DuCasse
“The future in cardiovascular medicine belongs to those who can integrate the biochemical and cellular research with clinical knowledge,” said Kathleen DuCasse, Chief Executive Officer of the Florida Heart Research Institute, in presenting the award.
Dr. Angiolillos ground-breaking efforts in both the clinical and basic science arenas have paved the way for these advances. Most recently, his outstanding work on physiology and genetics of platelet function, as well as on the mechanisms of atherosclerotic inflammation have advanced our understanding of coronary artery disease, as well as opening new vistas for potential therapies.
This prestigious award is granted to the individual within the State of Florida whose research is felt to have had the broadest impact on the advancement of knowledge in the diagnosis and/or treatment of cardiovascular disease. To be considered for the award, the researcher must be nominated by a colleague, conduct research within and be a resident of Florida, be active in the arena of clinical and/or basic science, and have reported the results of his or her work in the peer review arena of scientific meetings and/or publications. For his achievements in cardiovascular research, Dr. Angiolillo received $25,000 from the Florida Heart Research Institute to be applied toward future cardiac research in Florida.
Post Views: 1,012
